Coronary microangiopathy and cardiac hypertrophy

M Vogt1, W Motz, B Schwartzkopff

  • 1Medizinische Klinik and Poliklinik B, University of Düsseldorf, F.R.G.

Insights

Hypertensive patients often have impaired coronary vasodilator reserve, not linked to left ventricular hypertrophy. This reduced coronary reserve in hypertension stems from primary microvascular damage, independent of heart muscle thickening.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Hypertension Research

Background:

  • Coronary vasodilator reserve is frequently impaired in hypertensive patients, even without coronary heart disease.
  • The cause of reduced coronary reserve in hypertension—whether left ventricular hypertrophy or primary vascular changes—remains unclear.

Purpose of the Study:

  • To investigate whether impaired coronary reserve in hypertensive patients is due to left ventricular hypertrophy or primary vascular alterations.
  • To quantify coronary reserve and its relationship with left ventricular muscle mass and diastolic wall stress in hypertension.

Main Methods:

  • Coronary reserve was assessed in 54 hypertensive patients with angina and normal coronary arteries, and 12 normotensive controls.
  • Coronary blood flow was measured using the argon gas chromatographic method.
  • Coronary resistance was determined before and after dipyridamole administration; left ventricular muscle mass was assessed via ventriculography.

Main Results:

  • Hypertensive patients exhibited a 124% increase in minimal coronary resistance and a 38% reduction in coronary reserve compared to controls.
  • No significant correlation was found between coronary reserve, minimal coronary resistance, and left ventricular muscle mass or diastolic wall stress.
  • Myocardial oxygen consumption and resting coronary flow did not differ between hypertensive and normotensive groups.

Conclusions:

  • Reduced coronary vasodilator reserve in hypertensive patients is not directly related to the degree of left ventricular hypertrophy.
  • The findings suggest that primary microvascular lesions, independent of left ventricular hypertrophy, are responsible for impaired coronary reserve in hypertension.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
647
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810